Elevated Second-Trimester Maternal Urine Free Beta-Human Chorionic Gonadotropin Levels in Asian Pregnancies with Fetal Chromosomal Abnormalities

Objectives: To investigate the second trimester maternal urine free beta-human chorionic gonadotropin (hCG) levels of chromosomally abnormal pregnancies in Asians. Methods: Free beta-hCG levels were analyzed from the urine samples of 110 control and 17 chromosomally abnormal pregnancies, including 11 cases of Down syndrome, 1 case of trisomy 18, and other chromosomal abnormalities (one mosaic deletion and 4 translocations) from the second trimester of pregnancy. Results were normalized to urine creatinine (Cr) concentration and converted to the multiple of the median (MOM) level for the appropriate gestation. Gestational age of all cases was determined by ultrasound parameters. Results: The median free beta-hCG MOM levels of Down syndrome (4.02 MOM) and other chromosomally abnormal pregnancies (2.03 MOM) are significantly higher than that of normal pregnancies (0.99 MOM) (p = 0.002 and p = 0.024, respectively). Nine of 11 (81.8%) Down syndrome cases, one trisomy 18 case, and 2 of 5 (40%) other chromosomally abnormal cases would be expected to be above the 95th centile of the control values (2.95 MOM cut-off). Conclusion: Urine free beta-hCG could be a potential and useful marker in the detection of fetal Down syndrome and other chromosomal abnormalities in Asians.

[1]  T. Hung,et al.  Midtrimester maternal serum free beta-human chorionic gonadotropin levels: normal reference values for Taiwanese women. , 1998, Changgeng yi xue za zhi.

[2]  K. Spencer,et al.  Comparison of Down's Syndrome Screening Strategies in Asians combining Serum Free Beta‐hCG and Alpha‐fetoprotein with Maternal Age , 1997, Prenatal diagnosis.

[3]  K. Nicolaides,et al.  FIRST‐TRIMESTER URINE FREE BETA hCG, BETA CORE, AND TOTAL OESTRIOL IN PREGNANCIES AFFECTED BY DOWN'S SYNDROME: IMPLICATIONS FOR FIRST‐TRIMESTER SCREENING WITH NUCHAL TRANSLUCENCY AND SERUM FREE BETA hCG , 1997, Prenatal diagnosis.

[4]  J. Haddow,et al.  Maternal serum screening for Down syndrome in the United States: a 1995 survey. , 1997, American journal of obstetrics and gynecology.

[5]  K. Spencer,et al.  URINE FREE BETA hCG AND BETA CORE IN PREGNANCIES AFFECTED BY DOWN'S SYNDROME , 1996, Prenatal diagnosis.

[6]  F. Hsieh,et al.  Down Syndrome Screening in an Asian Population Using Alpha‐Fetoprotein and Free β‐hCG: A Report of the Taiwan Down Syndrome Screening Group , 1996, Obstetrics and gynecology.

[7]  H. Kozu,et al.  Maternal urinary free fl‐subunit of human chorionic gonadotrophin:creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy , 1996, British journal of obstetrics and gynaecology.

[8]  K. Spencer,et al.  Prenatal screening for trisomy 18 with free β human chorionic gonadotrophin as a marker , 1994 .

[9]  K. Spencer,et al.  First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A , 1994, Annals of clinical biochemistry.

[10]  N. Wald,et al.  The use of free β‐hCG in antenatal screening for Down's syndrome , 1994 .

[11]  K. Spencer,et al.  Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndrome , 1994, Prenatal diagnosis.

[12]  K. Spencer,et al.  Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker. , 1993, BMJ.

[13]  K. Spencer,et al.  Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin. , 1993, BMJ.

[14]  N. Wald,et al.  The use of free β‐hCG in antenatal screening for Down's syndrome , 1993 .

[15]  L. Cole,et al.  The deactivation of hCG by nicking and dissociation. , 1993, The Journal of clinical endocrinology and metabolism.

[16]  K. Spencer,et al.  Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers , 1992, Annals of clinical biochemistry.

[17]  J. Canick,et al.  Prenatal screening for Down's syndrome with use of maternal serum markers. , 1992, The New England journal of medicine.

[18]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. , 1991, Endocrinology.

[19]  D. Krantz,et al.  Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. , 1990, American journal of obstetrics and gynecology.

[20]  G. Braunstein,et al.  Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy. , 1988, The Journal of clinical endocrinology and metabolism.

[21]  B. Nisula,et al.  Metabolic clearance rates of the subunits of human chorionic gonadotropin in man. , 1979, The Journal of clinical endocrinology and metabolism.